All Updates

Today, the American Cancer Society and the American Cancer Society Cancer Action Network submitted a comment letter to the Office of Management and Budget strongly opposing a proposed rule that would change the federal government’s grantmaking framework.

Nearly 200 patient advocacy, public health and health care professional organizations sent a letter to the Senate declaring their strong support for the Clinical Trial Modernization Act (S. 4440/H.R. 3521). The bipartisan, bicameral legislation would help remove cost and geographic barriers that keep patients from enrolling and participating in clinical trials. The bill was introduced in the U.S. Senate by Sens. Tim Scott (R-SC) and Mark Warner (D-VA) in April 2026 and in the U.S. House of Representatives in May 2025 by Reps. Raul Ruiz (D-CA) and August Pfluger (R-TX).

The American Cancer Society Cancer Action Network (ACS CAN) called on the Nevada State Legislature to raise the state tax on cigarettes and all other tobacco products during a meeting of the Joint Interim Standing Committee on Revenue, Wednesday. Advocates hope to introduce a bill during the 2027 legislative session

Gov. Josh Green took a major step toward treating and preventing colorectal cancer in Hawai’i by signing HB 1969 into law which establishes a state-funded financial assistance program to offer screenings for uninsured and underinsured individuals and treatment for uninsured individuals. Follow up colonoscopies required after a non-invasive screening will

ATLANTA – Michael Cortes has joined the American Cancer Society Cancer Action Network (ACS CAN) as government relations director for the state of Georgia. In this role, Cortes will lead ACS CAN’s efforts to advance legislation and public policies to reduce the cancer burden. “I am honored to advocate

WASHINGTON, D.C. – The following is a statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network: “The FDA’s job is to protect public health, not expand the profit margins of Big Tobacco. Authorizing new modified risk claims for 20 Zyn nicotine products – including flavored

RALEIGH, N.C. – June 30, 2026 – With days left to act in the legislative session, cancer advocates urgently call on North Carolina lawmakers to pass legislation improving access to biomarker testing. The following statement can be attributed to American Cancer Society Cancer Action Network (ACS CAN) North Carolina Grassroots

Patient advocates and medical and public health leaders are renewing their call for an increased state investment in cancer research after the FY27 state budget maintained level funding for the New Jersey Commission on Cancer Research (NJCCR). The budget was finalized as support for legislation to increase annual state funding